Review

The Korean Journal of Medicine 1999;57(2):191-192.

(Idarubicin, Ara-c, and Topotecan in Patients with Refractory or Relapased Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome)

장준호, 이성태, 민유홍, 한지숙, 고윤웅

TOOLS

METRICS

Editorial Office: 101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791 Fax: +82-2-790-0993 E-mail: kaim@kams.or.kr